Results out show the generics have absolutely pounded Axiron since the start of this financial year. Can't imagine what the next quarterly is going to look like, before the court case is even heard. Over $10m in impairments as a result.
Impairment loss is a result of a re-assessment of the estimated future discounted cashflows from Axiron® assessing variables including the current market data for the Testosterone market in the United States and generic market penetration since 6 July 2017
Don't know how I ever got sucked into buying this rubbish a couple years back. Right up there with my worst investments.
- Forums
- ASX - By Stock
- Ann: Teva Launches Generic Version of Axiron in United States
Results out show the generics have absolutely pounded Axiron...
-
-
- There are more pages in this discussion • 8 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ACR (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.3¢ |
Change
-0.001(1.85%) |
Mkt cap ! $15.40M |
Open | High | Low | Value | Volume |
5.4¢ | 5.4¢ | 5.3¢ | $1.358K | 25.44K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 3401 | 5.3¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.4¢ | 4556 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 3401 | 0.053 |
2 | 293669 | 0.052 |
2 | 21500 | 0.051 |
2 | 217490 | 0.050 |
2 | 262000 | 0.049 |
Price($) | Vol. | No. |
---|---|---|
0.054 | 4556 | 1 |
0.057 | 16430 | 1 |
0.058 | 17258 | 1 |
0.059 | 18000 | 1 |
0.060 | 670 | 1 |
Last trade - 10.38am 08/10/2024 (20 minute delay) ? |
Featured News
ACR (ASX) Chart |